Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 3
Subtitle 10 - LABORATORIES
Chapter 10.10.05 - Medical Laboratories-Proficiency Testing
Section 10.10.05.05 - Cytology - Laboratory and Individual Standards
Universal Citation: MD Code Reg 10.10.05.05
Current through Register Vol. 51, No. 19, September 20, 2024
A. Primary Standard. A pathologist or cytotechnologist who examines gynecological cytology specimens from individuals in this State shall participate satisfactorily in an annual cytology PT program approved by the Secretary.
B. Laboratory Standards.
(1) A licensee
operating under a permit to examine gynecologic cytology specimens shall ensure
that each pathologist and cytotechnologist who examines gynecologic cytology
specimens participates in a cytology PT program conducted by the Department or
approved by the Secretary.
(2) An
in-State laboratory shall participate in the Department's PT program.
(3) An out-of-State laboratory shall
participate in either the Department's PT program or another equivalently
rigorous cytology PT program approved by the Secretary.
(4) A licensee employing an individual who
has failed a second testing event in an annual PT cycle shall:
(a) Prohibit the individual from examining
gynecologic specimens and provide or secure remedial training and education in
gynecologic cytology for the individual, which training and education includes
examination by the individual of gynecologic specimens in the individual's area
of failure; and
(b) Document the
individual's completion of education and training using a form provided by the
OHCQ.
(5) A licensee
employing an individual who has failed a first or subsequent PT event and who
does not obtain mandated retesting or retraining, or both, shall:
(a) Immediately remove that individual from a
position of examining gynecologic cytology specimens for the purpose of
reporting diagnostic test results to a health care provider; and
(b) Provide written notice to the OHCQ within
30 days after being informed of the individual's last test failure that the
individual is no longer examining gynecologic cytology specimens for the
purpose of reporting diagnostic test results to a health care
provider.
C. Individual Standards.
(1) A cytotechnologist
or pathologist who examines gynecological cytology specimens shall participate
in an annual PT event that involves the examination of a 10-slide or 20-slide
test set as set forth in 42
CFR § 493.945.
(2) An individual passes a testing event and
performs satisfactorily in PT when the individual scores at least 90 percent on
a 10-slide or 20-slide test set.
(3) An individual fails a testing event and
performs unsatisfactorily in PT if the individual:
(a) Scores less than 90 percent on a 10-slide
or 20-slide test set; or
(b) Fails
to take a scheduled retest without prior Department approval.
(4) An individual who fails the
annual testing event shall take a second test with another 10-slide test set:
(a) Within 45 days after receiving notice of
a test failure; or
(b) At a later
date with prior Department approval.
(5) An individual who fails a second test
shall:
(a) Cease examining gynecologic
specimens immediately upon being notified of the second failure;
(b) Complete at least 40 hours of remedial
training and education in gynecologic cytology that includes examining
gynecological specimens in the area of failure;
(c) Complete the required training and
education in a laboratory that operates under a:
(i) State permit for in-State laboratories,
or
(ii) Certificate issued by CMS
in the subdiscipline of gynecologic cytology for out-of-State
laboratories;
(d)
Document the required remedial training and education when completed, using a
form provided by the OHCQ, and submit the completed form to the OHCQ;
(e) Schedule and take a third test with a
20-slide test set within 30 days of completing the required remedial training
and education; and
(f) Begin
examining gynecologic cytology specimens only after the OHCQ informs the
individual that the individual obtained a passing score on the third
test.
(6) An individual
who fails a third or subsequent test shall:
(a) Complete at least 35 hours of documented,
formally structured, continuing education in diagnostic cytopathology that
focuses on the examination of gynecologic preparations;
(b) Document the education when completed,
using a form provided by the OHCQ, and submit the completed form to the
OHCQ;
(c) Schedule and take a
subsequent test with a 20-slide test set within 30 days of completing the
required continuing education; and
(d) Begin examining gynecologic cytology
specimens only after the OHCQ informs the individual that the individual
obtained a passing score on the test required under §C(6)(c) of this
regulation.
(7) An
individual who fails a first or subsequent testing event in an annual PT cycle
and who chooses not to complete mandatory retesting or remedial training, or
both, shall:
(a) Immediately cease examining
gynecologic cytology specimens and notify the OHCQ of this in writing;
and
(b) Reenter the PT process at
the point where the individual previously chose to withdraw from the testing
process, if the individual decides at a later date to satisfy PT
requirements.
Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.